Bidirectional association between cardiovascular disease and lung cancer in a prospective cohort study

Shanshan Zhang,Lei Liu,Shanshan Shi,Heng He,Qian Shen,Haoxue Wang,Shifan Qin,Jiang Chang,Rong Zhong
DOI: https://doi.org/10.1016/j.jtho.2023.09.004
IF: 20.121
2023-09-14
Journal of Thoracic Oncology
Abstract:Introduction The study aimed to prospectively investigate the bidirectional association between cardiovascular disease (CVD) and lung cancer, and whether this association differs across genetic risk levels. Methods This study prospectively followed 455,804 participants from the UK Biobank cohort who were free of lung cancer at baseline. Cox proportional hazards models were used to estimate hazard ratio (HR) for incident lung cancer according to CVD status. In parallel, similar approaches were used to assess the risk of incident CVD according to lung cancer status among 478,756 participants free of CVD at baseline. The bidirectional causal relations between these conditions were assessed using Mendelian randomization (MR) analysis. Besides, polygenic risk scores were estimated by integrating genome-wide association studies identified risk variants. Results During 4,007,477 person-years of follow-up, 2,006 incident lung cancer cases were documented. Compared with participants without CVD, those with CVD had HRs [95% confidence interval (CI)] of 1.49 (1.30-1.71) for non-small cell lung cancer (NSCLC), 1.80 (1.39-2.34) for lung squamous cell carcinoma (LUSC), and 1.25 (1.01-1.56) for lung adenocarcinoma (LUAD). After stratified by smoking status, significant associations of CVD with lung cancer risk were observed in former smokers (HR: 1.44, 95% CI: 1.20-1.74) and current smokers (HR: 1.38, 95% CI: 1.13-1.69), but not in never smokers (HR: 0.98, 95% CI: 0.60-1.61). Additionally, CVD was associated with lung cancer risk across each genetic risk level ( P heterogeneity = 0.336). In the second analysis, 32,974 incident CVD cases were recorded. Compared with those without lung cancer, the HRs (95% CI) for CVD were 2.33 (1.29-4.21) in NSCLC, 3.66 (1.65-8.14) in LUAD, and 1.98 (0.64-6.14) in LUSC. In particular, participants with lung cancer had a high risk of incident CVD in high genetic risk level (HR: 3.79, 95% CI: 1.57-9.13). No causal relations between these conditions were observed in MR analysis. Conclusions CVD is associated with an increased risk of NSCLC including LUSC and LUAD. NSCLC, particularly LUAD, is associated with a higher CVD risk. Awareness of this bidirectional association may improve prevention and treatment strategies for both diseases. Future clinical demands will require a greater focus on cardiac oncology.
oncology,respiratory system
What problem does this paper attempt to address?
The paper attempts to address the issue of exploring the bidirectional association between cardiovascular disease (CVD) and lung cancer, and whether this association varies at different levels of genetic risk. Specifically, the study aims to: 1. **Prospectively investigate the bidirectional relationship between cardiovascular disease and lung cancer**: By analyzing the risk of cardiovascular disease patients developing lung cancer and the risk of lung cancer patients developing cardiovascular disease, to assess whether there is a mutual influence between these two diseases. 2. **Evaluate the impact of genetic risk on this bidirectional association**: The study uses polygenic risk scores (PRS) to estimate an individual's genetic risk and explores whether the association between cardiovascular disease and lung cancer differs at different levels of genetic risk. 3. **Explore specific associations between different subtypes of cardiovascular disease (such as coronary heart disease, heart failure, stroke) and different histological subtypes of lung cancer (such as non-small cell lung cancer, lung squamous cell carcinoma, lung adenocarcinoma)**: The study not only focuses on the overall association between cardiovascular disease and lung cancer but also further subdivides the relationships between different subtypes. 4. **Use Mendelian randomization (MR) analysis to assess potential causal relationships**: By using genetic instrumental variables to evaluate the causal association between cardiovascular disease and lung cancer, to reduce the impact of confounding factors in observational studies. In summary, this study aims to comprehensively understand the complex relationship between cardiovascular disease and lung cancer, providing a scientific basis for prevention and treatment strategies for both.